1. CCLHD Research Repositories

Matthew M K Chan

View Statistics Email Alert RSS Feed

Profile

Loading... 2 0 20 0 false
Credit Name
Matthew M K Chan
Full Name
Chan, Matthew M K
ORCID
Loading... 3 0 20 0 false

Publications

Results 1-13 of 13 (Search time: 0.005 seconds).

PreviewIssue DateTitleAuthor(s)
1Oct-2020Platinum-containing regimens for triple-negative metastatic breast cancerChan, Matthew M K ; Egger, S.J.; Luo, Q.; Wilcken, N.
2May-2018Metastasis-specific patterns of response and progression with anti-PD-1 treatment in metastatic melanomaChan, Matthew M K ; Lee, J.H.J.; Lyle, M.; Menzies, A.M.; Lo, S.; Clements, A.; Cabral, N.L.; Kefford, R.F.; Long, G.V.
3Aug-2017Dose individualization of sunitinib in metastatic renal cell cancer: toxicity-adjusted dose or therapeutic drug monitoringChan, Matthew M K ; Sabanathan, D.; Zhang, A.; Fox, P.; Coulter, S.; Gebski, V.; Balakrishnar, B.; Liddle, C.; Gurney, H.
4Apr-2016sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistanceChan, Matthew M K ; Kaur, A.; Webster, M.R.; Marchbank, K.; Behera, R.; Ndoye, A.; Kugel 3rd, C.H.; Dang, V.M.; Appleton, J.; O'Connell, M.P.; Cheng, P.; Valiga, A.A.; Morissette, R.; McDonnell, N.B.; Ferrucci, L.; Kossenkov, A.V.; Meeth, K.; Tang, H.Y.; Yin, X.; Wood 3rd, W.H.; Lehrmann, E.; Becker, K.G.; Flaherty, K.T.; Frederick, D.T.; Wargo, J.A.; Cooper, Z.A.; Tetzlaff, M.T.; Hudgens, C.; Aird, K.M.; Zhang, R.; Xu, X.; Liu, Q.; Bartlett, E.; Karakousis, G.; Eroglu, Z.; Lo, R.S.; Menzies, A.M.; Long, G.V.; Johnson, D.B.; Sosman, J.; Schilling, B.; Schadendorf, D.; Speicher, D.W.; Bosenberg, M.; Ribas, A.; Weeraratna, A.T.
5Nov-2015A phase III randomized trial of adding topical nitroglycerin to first-line chemotherapy for advanced nonsmall-cell lung cancer: the Australasian lung cancer trials group NITRO trialChan, Matthew M K ; Davidson, A.; Veillard, A.S.; Hughes, B.G.; Boyer, M.; Briscoe, K.; Begbie, S.; Abdi, E.; Crombie, C.; Long, J.; Boyce, A.; Lewis, C.R.; Varma, S.; Broad, A.; Muljadi, N.; Chinchen, S.; Espinoza, D.; Coskinas, X.; Pavlakis, N.; Millward, M.; Stockler, M.R.
6Nov-2015Clinicopathologic features associated with efficacy and long-term survival in metastatic melanoma patients treated with BRAF or combined BRAF and MEK inhibitorsChan, Matthew M K ; Menzies, A.M.; Wilmott, J.S.; Drummond, M.; Lo, S.; Lyle, M.; Thompson, J.F.; Guminski, A.; Carlino, M.S.; Scolyer, R.A.; Kefford, R.F.; Long, G.V.
7Oct-2015Ipilimumab-induced hypophysitis in melanoma patients: an Australian case seriesChan, Matthew M K ; Lam, T.; Sweeting, A.N.; De Sousa, S.M.; Clements, A.; Carlino, M.S.; Long, G.V.; Tonks, K.T.; Chua, E.; Kefford, R.F.; Chipps, D.R.
8Sep-2015Clinical utility of ramucirumab in advanced gastric cancerChan, Matthew M K ; Sjoquist, K.M.; Zalcberg, J.R.
9Jun-2015Taxane-containing regimens for metastatic breast cancerChan, Matthew M K ; Ghersi, D.; Willson, M.L.; Chan, M.M.; Simes, J.; Donoghue, E.
10Jan-2015Arthritis and tenosynovitis associated with the anti-PD1 antibody pembrolizumab in metastatic melanomaChan, Matthew M K ; Kefford, R.F.; Carlino, M.; Clements, A.; Manolios, N.
11Oct-2014The nature and management of metastatic melanoma after progression on BRAF inhibitors: effects of extended BRAF inhibitionChan, Matthew M K ; Haydu, L.E.; Menzies, A.M.; Azer, M.W.; Klein, O.; Lyle, M.; Clements, A.; Guminski, A.; Kefford, R.F.; Long, G.V.
12Jul-2014Symptomatic Histologically Proven Necrosis of Brain following Stereotactic Radiation and Ipilimumab in Six Lesions in Four Melanoma PatientsChan, Matthew M K ; Du Four, S.; Hong, A.; Charakidis, M.; Duerinck, J.; Wilgenhof, S.; Wang, W.; Feng, L.; Michotte, A.; Okera, M.; Shivalingam, B.; Fogarty, G.; Kefford, R.; Neyns, B.
13Jul-2006Long-acting beta2-agonists for poorly reversible chronic obstructive pulmonary diseaseChan, Matthew M K ; Appleton, S.; Poole, P.; Smith, B.; Veale, A.; Lasserson, T.J.